National Inpatient Datasets May No Longer Be Appropriate for Overall Total Hip and Knee Arthroplasties Projections after Removal from Inpatient-Only Lists

Abstract

It is unknown if the National Inpatient Sample (NIS) remains suitable to conduct projections for total knee arthroplasty (TKA) and total hip arthroplasty (THA), after their removal from “inpatient-only lists” in 2018 and 2020, respectively. We aimed to: (1) quantify primary THA and TKA volume from 2008 to 2018; (2) project estimates of future volume of THA and TKA until 2050; and (3) compare projections based on NIS data from 2008 to 2018 and 2008 to 2017, respectively. We identified all primary THA and TKA performed from 2008 to 2018 from the NIS. The projected volumes of THA and TKA were modeled using negative binomial regression models while incorporating log-transformed population data from the Centers for Disease Control and Prevention. Annual volume increased by 26% for THA and 11% for TKA (2008/2018: THA: 360,891/465,559; TKA:592,352/657,294). Based on 2008 to 2018 data, THA volume is projected to grow 120%, to 1,119,942 THAs by 2050. While, based on 2008 to 2017 data, THA volume is projected to grow 136%, to 1,219,852 THAs by 2050. Based on 2008 to 2018 data, TKA volume is projected to grow 4%, to 794,852 TKAs by 2050. While, based on 2008 to 2017 data, TKA volume is projected to grow 28%, to 1,037,474 TKAs by 2050. Projections based on 2008 to 2017 data estimated up to 240,000 (23%) more annual TKAs by 2050, compared with projections based on 2008 to 2018 data. The largest discrepancy among THA projections was an 8.2% difference (99,000 THAs) for 2050. After 2018 for TKA, and potentially 2020 for THA, projections based on the NIS will have to be interpreted with caution and may only be appropriate to estimate future inpatient volume. Level of evidence is prognostic level II.

Keywords

THA - TKA - surgical volume - nationwide utilization - outpatient - shift

Data Availability

Yes, publicly available.

Publication History

Received: 07 November 2022

Accepted: 12 February 2023

Accepted Manuscript online:
17 February 2023

Article published online:
29 March 2023

• References

• 1 Singh JA, Yu S, Chen L, Cleveland JD. Rates of total joint replacement in the United States: future projections to 2020-2040 using the National Inpatient Sample. J Rheumatol 2019; 46 (09) 1134-1140
• 2 Sloan M, Premkumar A, Sheth NP. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am 2018; 100 (17) 1455-1460
• 3 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89 (04) 780-785
• 4 Kurtz SM, Ong KL, Lau E, Bozic KJ. Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021. J Bone Joint Surg Am 2014; 96 (08) 624-630
• 5 Bashinskaya B, Zimmerman RM, Walcott BP, Antoci V. Arthroplasty utilization in the United States is predicted by age-specific population groups. ISRN Orthop 2012; 2012: 1-8
• 6 Inacio MCS, Paxton EW, Graves SE, Namba RS, Nemes S. Projected increase in total knee arthroplasty in the United States - an alternative projection model. Osteoarthritis Cartilage 2017; 25 (11) 1797-1803
• 7 Stronach BM, Zhang X, Haas D, Iorio R, Anoushiravani A, Barnes CL. Worsening arthroplasty utilization with widening racial variance during the COVID-19 pandemic. J Arthroplasty 2022; 37 (07) 1227-1232
• 8 Heckmann ND, Bouz GJ, Piple AS. et al. Elective inpatient total joint arthroplasty case volume in the United States in 2020: effects of the COVID-19 pandemic. J Bone Joint Surg Am 2022; 104 (13) e56
• 9 Thirukumaran CP, Cai X, Glance LG. et al. Geographic variation and disparities in total joint replacement use for medicare beneficiaries: 2009 to 2017. J Bone Joint Surg Am 2020; 102 (24) 2120-2128
• 10 Best MJ, McFarland EG, Thakkar SC, Srikumaran U. Racial disparities in the use of surgical procedures in the US. JAMA Surg 2021; 156 (03) 274-281
• 11 Mota REM, Tarricone R, Ciani O, Bridges JF, Drummond M. Determinants of demand for total hip and knee arthroplasty: a systematic literature review. BMC Health Serv Res 2012; 12: 225
• 12 Khera R, Angraal S, Couch T. et al. Adherence to methodological standards in research using the National Inpatient Sample. JAMA 2017; 318 (20) 2011-2018
• 13 Emara AK, Zhou G, Klika AK. et al. Is there increased value in robotic arm-assisted total hip arthroplasty?: a nationwide outcomes, trends, and projections analysis of 4,699,894 cases. Bone Joint J 2021; 103-B [phone]
• 14 Emara AK, Zhou G, Klika AK. et al. Robotic-arm-assisted knee arthroplasty associated with favorable in-hospital metrics and exponentially rising adoption compared with manual knee arthroplasty. J Am Acad Orthop Surg 2021; 29 (24) e1328-e1342
• 15 Ng M, Golub I, Piuzzi N, Razi A, Wong C, Mont M. Outpatient primary total hip arthroplasty is a safe alternative to inpatient primary total hip arthroplasty: a matched-cohort analysis study. Surg Technol Int 2021; 39: sti39/1490
• 16 Rodríguez-Merchán EC. Outpatient total knee arthroplasty: is it worth considering?. EFORT Open Rev 2020; 5 (03) 172-179
• 17 Barnes CL, Iorio R, Zhang X, Haas DA. An examination of the adoption of outpatient total knee arthroplasty since 2018. J Arthroplasty 2020; 35 (6S): S24-S27
• 18 National Center for Health Statistics. U.S. Census Populations With Bridged Race Categories, at: https://www.cdc.gov/nchs/nvss/bridged_race.htm#data [accessed September 1, 2022]
• 19 DeCook CA. Outpatient joint arthroplasty: transitioning to the ambulatory surgery center. J Arthroplasty 2019; 34 (7S): S48-S50
• 20 Richards MR, Seward JA, Whaley CM. Removing Medicare's outpatient ban and Medicare and private surgical trends. Am J Manag Care 2021; 27 (03) 104-108